Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy

SH Kiaie, H Salehi-Shadkami, MJ Sanaei… - Journal of …, 2023 - Springer
Immune checkpoint (ICP) molecules expressed on tumor cells can suppress immune
responses against tumors. ICP therapy promotes anti-tumor immune responses by targeting …

[HTML][HTML] Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape

M Durán-Lobato, AM López-Estévez… - Advanced Drug Delivery …, 2021 - Elsevier
Biological macromolecule-based therapeutics irrupted in the pharmaceutical scene
generating a great hope due to their outstanding specificity and potency. However, given …

Drug delivery methods for cancer immunotherapy

E Pérez-Herrero, OL Lanier, N Krishnan… - Drug Delivery and …, 2024 - Springer
Despite the fact that numerous immunotherapy-based drugs have been approved by the
FDA for the treatment of primary and metastatic tumors, only a small proportion of the …

Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy

A Isser, NK Livingston, JP Schneck - Biomaterials, 2021 - Elsevier
T cells are often referred to as the 'guided missiles' of our immune system because of their
capacity to traffic to and accumulate at sites of infection or disease, destroy infected or …

Nanoparticles for generating antigen-specific T cells for immunotherapy

SE Est-Witte, NK Livingston, MO Omotoso… - Seminars in …, 2021 - Elsevier
T cell therapy shows promise as an immunotherapy in both immunostimulatory and
immunosuppressive applications. However, the forms of T cell-based therapy that are …

Shifting cold to hot tumors by nanoparticle-loaded drugs and products

I Ahmad, KKA Altameemi, MM Hani, AM Ali… - Clinical and …, 2024 - Springer
Cold tumors lack antitumor immunity and are resistant to therapy, representing a major
challenge in cancer medicine. Because of the immunosuppressive spirit of the tumor …